Tag: clinical trial
-
Radiopharmaceutical Therapy Boosts Radiation to Slow Prostate Cancer
New Findings from the LUNAR Trial A landmark phase II study, known as the LUNAR trial, reports that people with recurrent prostate cancer and a limited number of metastases lived significantly longer without disease progression when a radiopharmaceutical drug was given before targeted radiation therapy, compared with high-precision radiation alone. The randomized study evaluated whether…
-
Wegovy and Ozempic: Could Semaglutide Help Alcohol Dependence?
The new front in addiction research: GLP-1 drugs and alcohol Semaglutide, the active ingredient in Wegovy (weight loss) and Ozempic (diabetes), is being explored beyond its approved uses. Anecdotal reports have noted that some people on these injections drink less alcohol, prompting researchers to study whether semaglutide could help those struggling with alcohol dependence. A…
-
Nosebleeds to Cancer: A Man’s Journey
From nosebleeds to a life-changing diagnosis What began as frequent nosebleeds in November 2024 for a 41-year-old safety manager in Singapore would soon unfold into a life-changing medical journey. A family doctor linked the bleeding to a fever he had, and the episodes recurred during times of stress and exhaustion. When the nosebleeds intensified to…
-
Wegovy and Ozempic Could Help Alcohol Dependence: Early Findings
Background Wegovy and Ozempic are brand names for semaglutide, a GLP‑1 receptor agonist. While they are primarily used for obesity management and type 2 diabetes, researchers are beginning to explore whether these drugs might influence alcohol use disorders as well. In a small US study, investigators observed that some participants reduced their alcohol consumption while…
-
Nosebleeds to cancer: A man’s journey
Understanding nasopharyngeal cancer Nasopharyngeal cancer (NPC) is a cancer that originates in the nasopharynx, the upper part of the throat behind the nose. In Singapore, NPC remains one of the more common cancers, with roughly 300 new cases diagnosed each year. While NPC is more prevalent among Chinese men in this country, it does occur…
-
Semaglutide Could Aid Alcohol Dependence: Wegovy & Ozempic
New clues on semaglutide and alcohol dependence In recent years, semaglutide, the active ingredient in Wegovy and Ozempic, has drawn attention beyond weight loss and diabetes management. A small American study provides the first clinical hints that this GLP-1 receptor agonist could help people with alcohol use disorder by reducing the amount they drink during…
-
Nose cancer journey in Singapore: A man’s battle and hope
What is nasopharyngeal cancer (NPC)? Nasopharyngeal cancer (NPC) is a malignancy that develops in the nasopharynx, the upper part of the throat behind the nose. It can present with nosebleeds, a painless lump in the neck, hearing loss, and sometimes facial discomfort. In Singapore, NPC remains one of the more frequently diagnosed cancers, with roughly…
-
Huntington’s disease gene therapy offers hopeful prospects, questions
Promising but preliminary: what the results suggest A potential breakthrough in Huntington’s disease treatment has sparked cautious optimism within the community. The European biotech firm uniQure reported top-line findings from a small, early-stage trial of AMT-130, a gene therapy designed to address the genetic error behind Huntington’s disease. According to the company, those receiving the…
-
Huntington’s Disease Gene Therapy: Promise Amid Unanswered Questions
New Hope in Huntington’s Disease Gene Therapy A European biotech company, uniQure, has released preliminary results from an experimental gene therapy (AMT-130) aimed at Huntington’s disease. The data suggest the therapy could slow disease progression by about 75% over three years in patients receiving the highest dose. The treatment is delivered directly into the brain…
-
Breakthrough Blood Test for Alzheimer’s Screening in the UK
Introduction to the Alzheimer’s Blood Test In a significant advancement in the fight against Alzheimer’s disease, the United Kingdom has embarked on a clinical trial to evaluate a blood test dedicated to early screening for this debilitating condition. This initiative aims to enhance early diagnosis, which is critical for effective treatment and support. Why Early…